Emiltatug Ledadotin (Emi-Le) Granted Breakthrough Therapy Designation by the U.S. FDA for Adenoid Cystic Carcinoma (ACC)

Servier today announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to ...
ascopubs.org

Factors influencing surgical treatment of adenoid cystic carcinoma of the head and neck: A National Cancer Database analysis.

Pilot study evaluating the addition of cemiplimab in BRAF-mutant anaplastic thyroid cancer after progression on dabrafenib and trametinib. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Nature

Adenoid Cystic Carcinoma of the Breast

Adenoid cystic carcinoma (ACC) of the breast is a rare and distinctive form of breast cancer, accounting for less than 0.1% of all breast malignancies. Despite its triple‐negative immunophenotype, ...
EurekAlert!

B7-H4 as a therapeutic target in adenoid cystic carcinoma

BUFFALO, NY – December 4, 2024 – A new editorial was published in Oncotarget’s Volume 15 on November 22, 2024, entitled “B7-H4: A potential therapeutic target in adenoid cystic carcinoma.” Researchers ...
BioWorld

Remix’s REM-422 induces potent antitumor activity in preclinical adenoid cystic carcinoma

The c-MYB oncogene plays a key role in hematopoietic cell differentiation and proliferation. Genetic abnormalities and dysregulation of MYB have been found in several cancers, including adenoid cystic ...
ascopubs.org

Dosimetry of lutetium-177-PSMA-I&T radioligand therapy in recurrent/metastatic adenoid cystic carcinoma.

Clinical validation of a mesenchymal gene expression signature for prognosis and treatment decision making in early-stage oral cavity squamous cell carcinoma. This is an ASCO Meeting Abstract from the ...